RECRUITING

The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to investigate whether or not the investigators can utilize Body Surface Gastric Mapping to determine who would best benefit to receive G-POEM procedure and how Body Surface Gastric Mapping can be utilized with patients who have gastroparesis symptoms. the investigators may also be able to find more ways how Body Surface Gastric Mapping testing can benefit patients with gastroparesis and/or G-POEM procedure.

Official Title

The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM

Quick Facts

Study Start:2024-10-30
Study Completion:2026-06-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06493032

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * • Patients clinically eligible for G-Poem at our center.
  1. * • Pregnant or breast-feeding
  2. * Patients with gastroparesis due to spinal cord injuries due to difficulties in conducting the BSGM. Of note, we rarely see gastroparesis in this context.
  3. * Inability to perform BSGM: history of severe skin allergies or sensitivity to cosmetics or lotions; chronically damaged or vulnerable epigastric skin (fragile skin, wounds, inflammation); patients unable to remain in a relaxed reclined position for the test duration.
  4. * Patients with abdominal drains or tubes

Contacts and Locations

Study Contact

Jacqueline Peterman
CONTACT
317-278-9242
petermaj@iu.edu
Marita Salame, MD
CONTACT
masalame@iu.edu

Principal Investigator

Mohammad Al-Haddad, MD
PRINCIPAL_INVESTIGATOR
Indiana Unversity/Indiana University Health

Study Locations (Sites)

Indiana University Health University Hospital
Indianapolis, Indiana, 46202
United States

Collaborators and Investigators

Sponsor: Indiana University

  • Mohammad Al-Haddad, MD, PRINCIPAL_INVESTIGATOR, Indiana Unversity/Indiana University Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-30
Study Completion Date2026-06-01

Study Record Updates

Study Start Date2024-10-30
Study Completion Date2026-06-01

Terms related to this study

Additional Relevant MeSH Terms

  • Gastroparesis